Anavex Life Sciences Corp.

NASDAQ:AVXL

12.11 (USD) • At close December 27, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202420232022202120202019201820172016201520142013201220112010200920082007200620052004
Assets:
Current Assets:
Cash & Cash Equivalents 132.187151.024149.158152.10829.24922.18622.93127.449.18715.2917.2620.3450.0110.1350.2650.3510.00600.0120.0010.028
Short Term Investments 000000000000000000000
Cash and Short Term Investments 132.187151.024149.158152.10829.24922.18622.93127.449.18715.2917.2620.3450.0110.1350.2650.3510.00600.0120.0010.028
Net Receivables 2.4492.7093.1939.1374.8492.6431.870.010.0790.0770000.0010.038000000
Inventory 0000.0160-2.643000000000000000
Other Current Assets 0.9310.6530.3540.3720.4440.5011.2520.3360.180.1010.0890.0480.0010.0650.0230.05600000
Total Current Assets 135.567154.386152.705161.61634.54225.32924.32427.7869.44615.4697.3510.3930.0130.2010.3260.4070.00600.0120.0010.028
Non-Current Assets:
Property, Plant & Equipment, Net 0000000000.0010.00200.0010.0020.0040.0020.0010000
Goodwill 000000000000000000000
Intangible Assets 000000000000000000000
Goodwill and Intangible Assets 000000000000000000000
Long Term Investments 000000000000000000000
Tax Assets 000000000000000000000
Other Non-Current Assets 0000.016000.0520.0520.052000000000000
Total Non-Current Assets 0000.016000.0520.0520.0520.0010.00200.0010.0020.0040.0020.0010000
Total Assets 135.567154.386152.705161.61634.54225.32924.37627.8389.49915.477.3540.3930.0130.2030.330.4090.00700.0120.0010.028
Liabilities & Equity:
Current Liabilities:
Account Payables 9.6274.3223.8254.743.9893.5232.9553.5843.0612.4711.2211.7110.0020.410.7981.5920.7490.4630.0080.0170
Short Term Debt 0000000000.0850.1920.2110.2990.8682.4922.5071.5500.0200
Tax Payables 00000000-14.707000000000000
Deferred Revenue 0.84200.4440.44400000.0710.072-1.221-1.711-0.00200-4.098-2.2990000
Other Current Liabilities 4.8358.2126.3895.6153.3171.5160.929014.8370.1050.0280.032.5870.068000000.010.003
Total Current Liabilities 15.30412.53410.21410.7987.3065.043.8853.5843.1912.6611.4411.9532.8881.3453.294.0982.2990.4630.0280.0270.003
Non-Current Liabilities:
Long Term Debt 00000000005.720000000000
Deferred Revenue Non-Current 000000000000000000000
Deferred Tax Liabilities Non-Current 000000000000000000000
Other Non-Current Liabilities 4.83500000000000000000000
Total Non-Current Liabilities 4.83504.2695.6153.3171.51600005.720.9040000.16800000
Total Liabilities 15.30412.53410.21410.7987.3065.043.8853.5843.1912.6617.1612.8572.8881.3453.294.2662.2990.4630.0280.0270.003
Equity:
Preferred Stock 000000000000000000000
Common Stock 0.0850.0820.0780.0760.0620.0530.0460.0430.0360.0320.0470.0370.030.0270.0240.0210.020.020.0190.0030.002
Retained Earnings -336.071-293.069-245.564-197.586-159.677-133.397-108.932-91.479-78.018-63.281-52.573-41.205-37.505-29.203-21.896-12.562-7.063-1.712-0.132-0.106-0.014
Accumulated Other Comprehensive Income/Loss 000-000000-0.002-0.001-0.006-0.005-0.003-0.002-0.0010.1260000
Other Total Stockholders Equity 456.249434.839387.977348.328186.852153.634129.378115.68984.2974.06150.71438.70534.628.03418.9128.6844.6251.2490.0970.0770.038
Total Shareholders Equity 120.263141.852142.491150.81827.23720.2920.49224.2546.30812.8090.193-2.463-2.875-1.142-2.96-3.858-2.292-0.463-0.016-0.0260.026
Total Equity 120.263141.852142.491150.81827.23720.2920.49224.2546.30812.8090.193-2.463-2.875-1.142-2.96-3.858-2.292-0.463-0.016-0.0260.026
Total Liabilities & Shareholders Equity 135.567154.386152.705161.61634.54225.32924.37627.8389.49915.477.3540.3930.0130.2030.330.4090.00700.0120.0010.028